Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
530019
Company
Jubilant Pharmova Ltd
Exchange Received Time
24/09/2018 18:50:53
Exchange Disseminated Time
24/09/2018 18:50:56
Time Taken
00:00:03
Intimation Of Schedule Of Analyst / Institutional Investors Meeting By Our Wholly-Owned Subsidiary, Jubilant Pharma Limited |
9/24/2018 6:50:54 PM
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL') proposes to organise exploratory meetings with one or more international institutional investors located in different jurisdictions, between September 25, 2018 and November 30, 2018, in connection with JPL's proposed plan of fund raising.
The schedule may undergo change due to exigencies on the part of the investors or JPL.
A copy of the investor presentation to be shared with investors during the meetings is attached herewith. Further, the investor presentation along with certain related additional information shall also be available on the website of the Company (www.jubl.com).
The Company will provide further updates in this regard, if and when necessary.
Attachment
<< Back
Recently Viewed